Patents by Inventor Mark Lyte

Mark Lyte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230414679
    Abstract: The present disclosure relates to use of probiotic compositions and/or histamine degrading enzymes for the control of histamine in a farm production animal, companion animal, aquaculture, or a human, to reduce or eliminate the incidence of necrotizing enterocolitis and/or related inflammatory conditions in the gastrointestinal tract or skin, and behavioral conditions. The disclosure also relates to the probiotic compositions and/or histamine degrading enzymes.
    Type: Application
    Filed: June 22, 2023
    Publication date: December 28, 2023
    Inventor: Mark Lyte
  • Patent number: 11753617
    Abstract: Methods and compositions for enhancing or promoting germination of bacterial spores, and yeasts are disclosed herein. The composition of the present invention comprises an extract obtained from banana or any member belonging to the genus Musa that may be used alone or in a growth medium to promote and enhance germination of bacterial spores, growth of bacterial, yeast, and fungal cell cultures.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: September 12, 2023
    Assignee: Texas Tech University System
    Inventor: Mark Lyte
  • Publication number: 20230111960
    Abstract: The present disclosure is directed to dopamine producing probiotics to increase immune responses to vaccination and to provide increased immune protection. The present disclosure is further directed to dopamine producing synbiotic compositions, formulations, plants, and synthetic compounds and their use for targeted clinical and veterinary applications, for example, in promoting health and well-being and enhancing vaccine efficacy. The present disclosure also provides an approach for optimization of synbiotic delivery of a probiotic or other dopamine producing product with a dopamine precursor to beneficially aid in the use of such products for a variety of conditions and diseases, and particularly in the field of vaccines, whether prophylactic or therapeutic.
    Type: Application
    Filed: October 10, 2022
    Publication date: April 13, 2023
    Inventor: Mark Lyte
  • Publication number: 20230011355
    Abstract: The present invention relates to use of probiotic compositions and/or histamine degrading enzymes for the control of histamine in a farm production animal, companion animal, aquaculture, or a human, to reduce or eliminate the incidence of necrotizing enterocolitis and/or related inflammatory conditions in the gastrointestinal tract or skin, and behavioral conditions. The invention also relates to the probiotic compositions and/or histamine degrading enzymes.
    Type: Application
    Filed: December 23, 2020
    Publication date: January 12, 2023
    Inventor: Mark Lyte
  • Publication number: 20220338448
    Abstract: An artificial and/or simulated environment is used to raise a domestic or commercially raised animal to promote a positive health feedback and to minimize stress on the animal. The simulated environment is used to create the façade of a free range or cage free environment, while also minimizing the exposure to inclement weather, potential predators, and other unknown or stress-inducing situations. The results include animals that have higher resistance to diseases and have a lower stress. The artificial environment can be created by projecting or otherwise showing images and/or videos depicting simulation of environments, climate, and/or other unknown situations to normalize the animals to the same.
    Type: Application
    Filed: April 26, 2022
    Publication date: October 27, 2022
    Inventors: Melha Mellata, James H. Oliver, Mark Lyte, Suzanne Theresa Millman Hartline, Rafael Radkowski, Graham Redweik
  • Publication number: 20220313751
    Abstract: The present invention is directed to synbiotic compositions of probiotic strains and prebiotics, along with uses thereof for targeted human and animal applications, for example, in promoting health and well-being and/or treating therapeutic conditions. The present invention is also directed to methods of probiotic selection and detection of strains with the ability to produce neurochemicals in the gastrointestinal tract of a subject, providing a microbial endocrinology-based mechanism and approach for optimization of synbiotic delivery of a probiotic with a neurochemical precursor. Still further the present invention is directed to industrial applications for production of dopamine utilizing methods and media suitable for the same.
    Type: Application
    Filed: May 5, 2022
    Publication date: October 6, 2022
    Inventors: Mark Lyte, Daniel Nicholas Villageliu
  • Patent number: 11357803
    Abstract: The present invention is directed to synbiotic compositions of probiotic strains and prebiotics, along with uses thereof for targeted human and animal applications, for example, in promoting health and well-being and/or treating therapeutic conditions. The present invention is also directed to methods of probiotic selection and detection of strains with the ability to produce neurochemicals in the gastrointestinal tract of a subject, providing a microbial endocrinology-based mechanism and approach for optimization of synbiotic delivery of a probiotic with a neurochemical precursor. Still further the present invention is directed to industrial applications for production of dopamine utilizing methods and media suitable for the same.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: June 14, 2022
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Mark Lyte, Daniel Nicholas Villageliu
  • Publication number: 20210332396
    Abstract: The present invention relates to nucleic acid molecules from regions of Enterococcus spp. genomes which are associated with the production of dopamine The invention also relates to proteins encoded by such nucleic acid molecules as well as nucleic acid markers which are associated with high dopamine production. Moreover, the invention relates to uses of such molecules, including, but not limited to, transforming or transfecting cells or organisms with constructs containing the nucleic acid molecules to create cells or organisms with enhanced dopamine production. The present invention is also directed to kits for identifying bacteria which may be capable of producing dopamine based on the detection of the nucleic acid molecules.
    Type: Application
    Filed: September 23, 2019
    Publication date: October 28, 2021
    Inventors: Mark Lyte, Daniel Nicholas Villageliu
  • Publication number: 20210155968
    Abstract: The present invention is directed to methods of probiotic selection and use based on the capability of microbial biogenic amine uptake as a method for targeted clinical and veterinary applications, including promoting health and well-being and/or treating therapeutic conditions. The present invention utilizes a microbially-focused approach for the development of drug selection and/or probiotic administration in a variety of diseases and disorders.
    Type: Application
    Filed: February 1, 2021
    Publication date: May 27, 2021
    Inventors: Mark Lyte, David Robert Brown
  • Patent number: 10941433
    Abstract: The present invention is directed to methods of probiotic selection and use based on the capability of microbial biogenic amine uptake as a method for targeted clinical and veterinary applications, including promoting health and well-being and/or treating therapeutic conditions. The present invention utilizes a microbially-focused approach for the development of drug selection and/or probiotic administration in a variety of diseases and disorders.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: March 9, 2021
    Assignees: IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC., REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Mark Lyte, David Robert Brown
  • Publication number: 20200339943
    Abstract: Methods and compositions for enhancing or promoting germination of bacterial spores, and yeasts are disclosed herein. The composition of the present invention comprises an extract obtained from banana or any member belonging to the genus Musa that may be used alone or in a growth medium to promote and enhance germination of bacterial spores, growth of bacterial, yeast, and fungal cell cultures.
    Type: Application
    Filed: June 12, 2020
    Publication date: October 29, 2020
    Inventor: Mark Lyte
  • Publication number: 20200297784
    Abstract: The present invention is directed to synbiotic compositions of probiotic strains and prebiotics, along with uses thereof for targeted human and animal applications, for example, in promoting health and well-being and/or treating therapeutic conditions. The present invention is also directed to methods of probiotic selection and detection of strains with the ability to produce neurochemicals in the gastrointestinal tract of a subject, providing a microbial endocrinology-based mechanism and approach for optimization of synbiotic delivery of a probiotic with a neurochemical precursor. Still further the present invention is directed to industrial applications for production of dopamine utilizing methods and media suitable for the same.
    Type: Application
    Filed: September 21, 2018
    Publication date: September 24, 2020
    Inventors: Mark Lyte, Daniel Nicholas Villageliu
  • Patent number: 10696942
    Abstract: Methods and compositions for enhancing or promoting germination of bacterial spores, and yeasts are disclosed herein. The composition of the present invention comprises an extract obtained from banana or any member belonging to the genus Musa that may be used alone or in a growth medium to promote and enhance germination of bacterial spores, growth of bacterial, yeast, and fungal cell cultures.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: June 30, 2020
    Assignee: Texas Tech University System
    Inventor: Mark Lyte
  • Publication number: 20190040444
    Abstract: The present invention is directed to methods of probiotic selection and use based on the capability of microbial biogenic amine uptake as a method for targeted clinical and veterinary applications, including promoting health and well-being and/or treating therapeutic conditions. The present invention utilizes a microbially-focused approach for the development of drug selection and/or probiotic administration in a variety of diseases and disorders.
    Type: Application
    Filed: June 15, 2018
    Publication date: February 7, 2019
    Inventors: Mark Lyte, David Robert Brown
  • Publication number: 20180094234
    Abstract: Methods and compositions for enhancing or promoting germination of bacterial spores, and yeasts are disclosed herein. The composition of the present invention comprises an extract obtained from banana or any member belonging to the genus Musa that may be used alone or in a growth medium to promote and enhance germination of bacterial spores, growth of bacterial, yeast, and fungal cell cultures.
    Type: Application
    Filed: November 22, 2017
    Publication date: April 5, 2018
    Inventor: Mark Lyte
  • Patent number: 9796958
    Abstract: We describe the production and use of an extract obtained from Musa spp., preferably from bananas, in the promotion of growth of Gram-positive bacteria such as lactic acid bacteria. The extract is also useful for growth enhancement of environmentally-stressed Gram negative bacteria. Fermented foods containing such extracts are also described.
    Type: Grant
    Filed: November 7, 2006
    Date of Patent: October 24, 2017
    Assignee: Plant Bioscience Limited
    Inventors: Primrose Pamela Elaine Freestone, Richard David Haigh, Mark Lyte
  • Publication number: 20140295482
    Abstract: Methods and compositions for enhancing or promoting germination of bacterial spores, and yeasts are disclosed herein. The composition of the present invention comprises an extract obtained from banana or any member belonging to the genus Musa that may be used alone or in a growth medium to promote and enhance germination of bacterial spores, growth of bacterial, yeast, and fungal cell cultures.
    Type: Application
    Filed: November 2, 2012
    Publication date: October 2, 2014
    Inventor: Mark Lyte
  • Publication number: 20090087517
    Abstract: We describe the production and use of an extract obtained from Musa spp., preferably from bananas, in the promotion of growth of Gram-positive bacteria such as lactic acid bacteria. The extract is also useful for growth enhancement of environmentally-stressed Gram negative bacteria. Fermented foods containing such extracts are also described.
    Type: Application
    Filed: November 7, 2006
    Publication date: April 2, 2009
    Inventors: Primrose Pamela Elaine Freestone, Richard David Haigh, Mark Lyte
  • Patent number: 6649398
    Abstract: A bacterial autoinducer and method for isolating and purifying a bacterial autoinducer form a sample comprising the steps of collecting a sample containing the autoinducer, fractionating the sample to isolate fractions corresponding to molecular weights of approximately 300-1500 Dalton, and eluting the isolate on an anion-exchange chromatographic column and selecting the faction containing the autoinducer.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: November 18, 2003
    Assignee: University of Leicester
    Inventors: Primrose Pamela Elaine Freestone, Peter Humphrey Williams, Mark Lyte, Richard David Haigh
  • Publication number: 20020068330
    Abstract: The present invention concerns a novel bacterial autoinducer, methods of its manufacture, isolation and purification, uses of autoinducer isolated and purified using same, and the uses of the autoinducer.
    Type: Application
    Filed: July 12, 2001
    Publication date: June 6, 2002
    Inventors: Primrose Pamela Elaine Freestone, Peter Humphrey Williams, Mark Lyte, Richard David Haigh